Clinical Trial: Staging Candidiasis in ICU Patients
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Staging Candidiasis in ICU Patients
Brief Summary: Our primary objective is to evaluate the relevance of the early determination of Candida infection status among non-neutropenic patients hospitalized over 48 hours in ICUs.
Detailed Summary:
Sponsor: Centre Hospitalier Universitaire de Nīmes
Current Primary Outcome: Number of positive Candidiasis tests [ Time Frame: 7 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Number of positive Candidiasis tests [ Time Frame: 2 days ]Number of tests (score of 0 to 4) positive for Candida. Tests include (1) anti-candida antibody ELISA kit; (2) candida antigen ELISA kit; (3) detection of ciruclating Candida DNA via SYBR Breen qPCR Master mix; (4) colonization index based on mycological examination of five out of the following: urine, oral swab, bronchial aspirate, anal swab, swab of a central venous line, gastric liquid.
- Patient leaves ICU unit, yes/no [ Time Frame: 1 month ]
- Patient passes away in ICU unit, yes/no [ Time Frame: 1 month ]
- Patient has been prescribed an antifungal treatment in the past month, yes/no [ Time Frame: 1 month ]
Original Secondary Outcome: Same as current
Information By: Centre Hospitalier Universitaire de Nīmes
Dates:
Date Received: March 24, 2011
Date Started: October 2011
Date Completion:
Last Updated: March 26, 2015
Last Verified: March 2015